Voyager Therapeutics (VYGR) announced that it has selected a lead development candidate, VY1706, for its tau silencing gene therapy program in ...

Candidate VY1706 demonstrates significant reductions of tau at low doses in NHP study; IND and CTA filings anticipated in 2026 -- VY1706 is the ...

Jaguar has unveiled a new logo that emphasizes its posh British pronunciation as it transitions into a 'new era' that ...

In the review, Ferrer Isidro from the University of Barcelona and Reial Acadèmia de Medicina de Catalunya, explores the differences in brain aging and Alzheimer's disease between humans and their ...

Impact Link Townsend Davis, who lives in Brooklyn, New York, and his wife Bridget had been married for a decade when she was diagnosed with early-onset Alzheimer's in June 2015. She was 51 ...

Alzheimer's disease affects more than 50 million people worldwide, often devastating both the individuals who have it and their families and loved ones. It has no known cure, and the slow ...

Nov. 14, 2024 — Researchers have linked disease-related proteins and genes to identify specific cellular pathways responsible for Alzheimer's genesis and progression. The proteins were gathered ...

U.S. 10 Year Treasury Note 0.0340 4.4110% ...

Eighty Alzheimer's patients have been treated with a vaccine in a revolutionary attempt to reverse the disease. Doctors involved in the trials say they are only months away from discovering ...

Nearly 46,000 electric vehicles from Kia, Hyundai and Genesis are being recalled in Canada over a potential power loss issue ...

Rates of obesity in Canada have steadily increased in recent years making obesity one of the country’s biggest health problems. Being overweight or obese increases the risk of developing a ...

Alzheimer’s Association Quality Control (QC) Program brings together laboratories across the globe with the aim of standardizing the measurement of Alzheimer's biomarkers. The program aims to monitor ...